๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice

โœ Scribed by Adrien Croquelois; Alex Blindenbacher; Luigi Terracciano; Xueya Wang; Igor Langer; Freddy Radtke; Markus H. Heim


Book ID
102850505
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
517 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


The discovery that the human Jagged1 gene (JAG1) is the Alagille syndrome disease gene indicated that Notch signaling has an important role in bile duct homeostasis. The functional study of this signaling pathway has been difficult because mice with targeted mutations in Jagged1, Notch1, or Notch2 have an embryonic lethal phenotype. We have previously generated mice with inducible Notch1 disruption using an interferon-inducible Cre-recombinase transgene in combination with the loxP flanked Notch1 gene. We used this conditional Notch1 knockout mouse model to investigate the role of Notch1 signaling in liver cell proliferation and differentiation. Deletion of Notch1 did not result in bile duct paucity, but, surprisingly, resulted in a continuous proliferation of hepatocytes. In conclusion, within weeks after Notch1 inactivation, the mice developed nodular regenerative hyperplasia without vascular changes in the liver.


๐Ÿ“œ SIMILAR VOLUMES


Alpha-1-antitrypsin distribution in nodu
โœ Swan N. Thung ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 262 KB

editor, indicating topics they would like to comment on. They are welcome to telephone (203/785-7169 or 203/932-5711) to express their willingness to contribute, to indicate a specific article they think worthy of comment or to identify potential authors of future HE-PATOLOGY Elsewhere commentaries.

Nodular regenerative hyperplasia of the
โœ Khalid A. Al-Mukhaizeem; Arthur Rosenberg; Averell H. Sherker ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 1 views

## Abstract Portal hypertension has been described in a wide variety of hematological disorders, especially myeloproliferative and lymphoproliferative disorders. Its clinical manifestations may include bleeding esophageal varices, ascites, or hepatic encephalopathy. In patients with hematological d